PD-1 blockade potentiates HIV latency reversal ex vivo in CD4+ T cells from ART-suppressed individuals
The immune checkpoint molecule PD-1 is expressed on a fraction of CD4+ T cells latently infected with HIV, but whether PD-1 plays a functional role in reservoir persistence remains unknown. Here, Fromentin et al. show that PD-1 blockade potentiates latency reversal ex vivo in CD4+ T cells from ART s...
Saved in:
Main Authors: | Rémi Fromentin, Sandrina DaFonseca, Cecilia T. Costiniuk, Mohamed El-Far, Francesco Andrea Procopio, Frederick M. Hecht, Rebecca Hoh, Steven G. Deeks, Daria J. Hazuda, Sharon R. Lewin, Jean-Pierre Routy, Rafick-Pierre Sékaly, Nicolas Chomont |
---|---|
Format: | article |
Language: | EN |
Published: |
Nature Portfolio
2019
|
Subjects: | |
Online Access: | https://doaj.org/article/e996a4e085b845f09a6cdde3b15c9886 |
Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
Similar Items
-
The Tat Inhibitor Didehydro-Cortistatin A Prevents HIV-1 Reactivation from Latency
by: Guillaume Mousseau, et al.
Published: (2015) -
Single-cell TCR sequencing reveals phenotypically diverse clonally expanded cells harboring inducible HIV proviruses during ART
by: Pierre Gantner, et al.
Published: (2020) -
Potential Biomarkers for the Efficacy of PD-1-PD-L Blockade in Cancer
by: Grecea M, et al.
Published: (2021) -
PD-1/PD-L1 checkpoint blockade harnesses monocyte-derived macrophages to combat cognitive impairment in a tauopathy mouse model
by: Neta Rosenzweig, et al.
Published: (2019) -
Molecular mechanism of PD-1/PD-L1 blockade via anti-PD-L1 antibodies atezolizumab and durvalumab
by: Hyun Tae Lee, et al.
Published: (2017)